Short-Term Overfeeding Increases Circulating Adiponectin Independent of Obesity Status

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Cahill, Farrell ^a   Amini, Peyvand ^a   Wadden, Danny ^a   Khalili, Sammy ^a   Randell, Edward ^a   Vasdev, Sudesh ^a   Gulliver, Wayne ^a   Sun, Guang ^a  

^a MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGE DISTRIBUTION; ARTICLE; BODY FAT DISTRIBUTION; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE ASSOCIATION; GLUCOSE BLOOD LEVEL; HOMEOSTATIC MODEL ASSESSMENT INSULIN RESISTANCE; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; OBESITY; OVERNUTRITION; PANCREAS ISLET BETA CELL; PHENOTYPE; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; UPREGULATION;

ADIPONECTIN; ADULT; BLOOD GLUCOSE; BODY COMPOSITION; HUMANS; HYPERPHAGIA; LIPID METABOLISM; MALE; OBESITY; PHENOTYPE; TIME FACTORS; YOUNG ADULT;

EID: 84883361143     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0074215     Document Type: Article

References (45)

1. Shea J, Randell E, Vasdev S, Wang PP, Roebothan B, et al. (2007) Serum retinol-binding protein 4 concentrations in response to short-term overfeeding in normal-weight, overweight, and obese men. Am J Clin Nutr 86: 1310-1315.
2. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, et al. (2002) The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. Jama 288: 2709-2716.
3. Calle EE, Kaaks R, (2004) Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 4: 579-591.
4. Wozniak SE, Gee LL, Wachtel MS, Frezza EE, (2009) Adipose tissue: the new endocrine organ? A review article. Dig Dis Sci 54: 1847-1856.
5. Kershaw EE, Flier JS, (2004) Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 89: 2548-2556.
6. Trayhurn P, Wood IS, (2004) Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr 92: 347-355.
7. Farooqi IS, Matarese G, Lord GM, Keogh JM, Lawrence E, et al. (2002) Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. J Clin Invest 110: 1093-1103.
8. Lou PH, Yang G, Huang L, Cui Y, Pourbahrami T, et al. (2010) Reduced body weight and increased energy expenditure in transgenic mice over-expressing soluble leptin receptor. PLoS One 5: e11669.
9. Steinberg GR, Parolin ML, Heigenhauser GJ, Dyck DJ, (2002) Leptin increases FA oxidation in lean but not obese human skeletal muscle: evidence of peripheral leptin resistance. Am J Physiol Endocrinol Metab 283: E187-192.
10. Hotta K, Funahashi T, Bodkin NL, Ortmeyer HK, Arita Y, et al. (2001) Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys. Diabetes 50: 1126-1133.
11. Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, et al. (2002) Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 8: 1288-1295.
12. Moreno-Aliaga MJ, Lorente-Cebrian S, Martinez JA, (2010) Regulation of adipokine secretion by n-3 fatty acids. Proc Nutr Soc 69: 324-332.
13. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, et al. (2001) Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 86: 1930-1935.
14. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, et al. (1999) Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257: 79-83.
15. Yang WS, Lee WJ, Funahashi T, Tanaka S, Matsuzawa Y, et al. (2001) Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. J Clin Endocrinol Metab 86: 3815-3819.
16. Matsubara M, Maruoka S, Katayose S, (2002) Inverse relationship between plasma adiponectin and leptin concentrations in normal-weight and obese women. Eur J Endocrinol 147: 173-180.
17. Cnop M, Havel PJ, Utzschneider KM, Carr DB, Sinha MK, et al. (2003) Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia 46: 459-469.
18. Cote M, Mauriege P, Bergeron J, Almeras N, Tremblay A, et al. (2005) Adiponectinemia in visceral obesity: impact on glucose tolerance and plasma lipoprotein and lipid levels in men. J Clin Endocrinol Metab 90: 1434-1439.
19. Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, et al. (2000) Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 20: 1595-1599.
20. Kubota N, Terauchi Y, Yamauchi T, Kubota T, Moroi M, et al. (2002) Disruption of adiponectin causes insulin resistance and neointimal formation. J Biol Chem 277: 25863-25866.
21. Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, et al. (2001) The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 7: 941-946.
22. Berg AH, Combs TP, Du X, Brownlee M, Scherer PE, (2001) The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med 7: 947-953.
23. Maeda N, Shimomura I, Kishida K, Nishizawa H, Matsuda M, et al. (2002) Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat Med 8: 731-737.
24. Sun G, Bishop J, Khalili S, Vasdev S, Gill V, et al. (2007) Serum visfatin concentrations are positively correlated with serum triacylglycerols and down-regulated by overfeeding in healthy young men. Am J Clin Nutr 85: 399-404.
25. Cahill F, Shea JL, Randell E, Vasdev S, Sun G (2011) Serum peptide YY in response to short-term overfeeding in young men. Am J Clin Nutr.
26. Mauriege P, Despres JP, Marcotte M, Tremblay A, Nadeau A, et al. (1992) Adipose tissue lipolysis after long-term overfeeding in identical twins. Int J Obes Relat Metab Disord 16: 219-225.
27. Brons C, Jensen CB, Storgaard H, Hiscock NJ, White A, et al. (2009) Impact of short-term high-fat feeding on glucose and insulin metabolism in young healthy men. J Physiol 587: 2387-2397.
28. Brinc D, Chan MK, Venner AA, Pasic MD, Colantonio D, et al. (2012) Long-term stability of biochemical markers in pediatric serum specimens stored at-80 degrees C: a CALIPER Substudy. Clin Biochem 45: 816-826.
29. Pischon T, Hotamisligil GS, Rimm EB, (2003) Adiponectin: stability in plasma over 36 hours and within-person variation over 1 year. Clin Chem 49: 650-652.
30. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, et al. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412-419.
31. Sun G, Vasdev S, Martin GR, Gadag V, Zhang H, (2005) Altered calcium homeostasis is correlated with abnormalities of fasting serum glucose, insulin resistance, and beta-cell function in the Newfoundland population. Diabetes 54: 3336-3339.
32. Bray GA (2003) Contemporary diagnosis and management of obesity and the metabolic syndrome. Newton, PA: Handbooks in Health Care.
33. World_Health_Organization (2000) Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser 894: i-xii, 1-253.
34. Christiansen T, Paulsen SK, Bruun JM, Ploug T, Pedersen SB, et al. (2010) Diet-induced weight loss and exercise alone and in combination enhance the expression of adiponectin receptors in adipose tissue and skeletal muscle, but only diet-induced weight loss enhanced circulating adiponectin. J Clin Endocrinol Metab 95: 911-919.
35. Varady KA, Tussing L, Bhutani S, Braunschweig CL, (2009) Degree of weight loss required to improve adipokine concentrations and decrease fat cell size in severely obese women. Metabolism 58: 1096-1101.
36. Hu E, Liang P, Spiegelman BM, Lebas E, Paquot N, et al. (1996) AdipoQ is a novel adipose-specific gene dysregulated in obesity[Adiponectin: a new adipocytokine]. J Biol Chem 271: 10697-10703.
37. Yamauchi T, Kamon J, Waki H, Imai Y, Shimozawa N, et al. (2003) Globular adiponectin protected ob/ob mice from diabetes and ApoE-deficient mice from atherosclerosis. J Biol Chem 278: 2461-2468.
38. Kim JY, van de Wall E, Laplante M, Azzara A, Trujillo ME, et al. (2007) Obesity-associated improvements in metabolic profile through expansion of adipose tissue. J Clin Invest 117: 2621-2637.
39. Combs TP, Pajvani UB, Berg AH, Lin Y, Jelicks LA, et al. (2004) A transgenic mouse with a deletion in the collagenous domain of adiponectin displays elevated circulating adiponectin and improved insulin sensitivity. Endocrinology 145: 367-383.
40. Astrand O, Carlsson M, Nilsson I, Lindstrom T, Borga M, et al. (2010) Weight gain by hyperalimentation elevates C-reactive protein levels but does not affect circulating levels of adiponectin or resistin in healthy subjects. Eur J Endocrinol 163: 879-885.
41. Ukkola O, Teran-Garcia M, Tremblay A, Despres JP, Bouchard C, (2008) Adiponectin concentration and insulin indicators following overfeeding in identical twins. J Endocrinol Invest 31: 132-137.
42. Bullen JW Jr, Bluher S, Kelesidis T, Mantzoros CS, (2007) Regulation of adiponectin and its receptors in response to development of diet-induced obesity in mice. Am J Physiol Endocrinol Metab 292: E1079-1086.
43. Pellme F, Smith U, Funahashi T, Matsuzawa Y, Brekke H, et al. (2003) Circulating adiponectin levels are reduced in nonobese but insulin-resistant first-degree relatives of type 2 diabetic patients. Diabetes 52: 1182-1186.
44. Wang Y, Lam KS, Yau MH, Xu A, (2008) Post-translational modifications of adiponectin: mechanisms and functional implications. Biochem J 409: 623-633.
45. Hajri T, Tao H, Wattacheril J, Marks-Shulman P, Abumrad NN, (2011) Regulation of adiponectin production by insulin: interactions with tumor necrosis factor-alpha and interleukin-6. Am J Physiol Endocrinol Metab 300: E350-360.